DENVER, Jan. 11, 2006 (PRIMEZONE) -- Medical International Technology Inc. (OTCBB:MDLH) (http://www.mitcanada.ca) a developer and manufacturer of patented needle-free jet injectors for human and animal inoculation, is pleased to announce the sale of its AGRO-JET MIT IIP low-pressure, needle-free injectors designed for animal use to a distributor in Turkey, to help fight the deadly H5N1 strain of bird flu virus in Turkey.
Three Deaths in Turkey Last Week
The AGRO-JET Needle-Free injector will be used to inoculate poultry in Turkey to prevent and eliminate cross contamination. This follows the death of three people in Turkey this past week. According to news reports, all the deaths occurred in people who had close proximity to infected birds. Fifteen reported cases of the H5N1 strain of bird flu are still ongoing in Turkey.
At the present time, the world's poultry industry commonly uses a needle/syringe to inoculate all birds which are at risk of infection. The current method for inoculation requires that the needle be changed after a few hundred birds have been injected. This method poses a major problem as cross contamination may occur and more importantly, increases the risk of infecting the person inoculating, with an accidental needle wound.
"Medical International Technology Inc. is pleased to be able to continue to provide a safer, needle-free injection solution to the poultry industry," stated Mr. Karim Menassa, President and CEO of Medical International Technology Inc. "With the use of our product, we can safely inoculate as much poultry as possible in Turkey and help prevent the spread of this deadly disease to humans."
This press release is available on the Medical International Investor Relation's site for investor questions, commentary and feedback. Investors are asked to visit http://www.agoracom.com and select the Medical International Investor Relations HUB. Alternatively, investors can e-mail their questions or comments directly to MDIR@agoracom.com or asked to be placed on the Medical International investor e-mail list to receive all future press releases directly.
Karim Menassa, President On Behalf of the Board of Directors
About Medical International Technology, Inc.
MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.
The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology, Inc. takes no obligation to update or correct forward-looking statements.
The Medical International Technology, Inc. logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2204